Publication date: April 15, 2024
The issue of the right to abortion in Poland is currently a lively topic of political discussions aimed at changing existing regulations in a way that gives women the right to decide about their own body. Currently, attention is focused on four projects (drafts) bringing changes in the analyzed topics:
Publication date: April 15, 2024
On April 16, 2024, Crowne Plaza Warsaw, The HUB, KIELTYKA GLADKOWSKI’s lawyers will take part in Palo Alto Networks event IGNITE ON TOUR CENTRAL EASTERN EUROPE CYBERSECURITY FOR THE AI ERA.
This is one-day cybersecurity strategy and networking event specifically for cybersecurity leaders and influencers.
KIELTYKA GLADKOWSKI will take part in the event with its initiative iSTART1® programme devoted to cybersecurity and new technologies.
The topics discussed will be disruptive technologies, such as AI/ML, cloud computing, and IoT, which are fueling digital transformation while increasing the risk of cyber threats.
Publication date: April 05, 2024
Conversational AI and AI powered video bots for health education
On March 19th 2024 the lawyers of KIELTYKA GLADKOWSKI took part in the workshop devoted to the use of AI in patient engagement.
The workshop focused on the utilization of artificial intelligence (AI) in patient care and was led by Lawrence Byrd, Senior Director of Communications APIs at Vonage. The Vonage company is a global cloud communication leader providing Apps and APIs (such as AI, Video, Voice, SMS, UC, and more) and is a prominent supplier of embedded video for hundreds of global Telehealth innovators. Vonage also assists businesses in stimulating their digital transformation.
Publication date: April 04, 2024
The Polish Ministry of Development and Technology has prepared a draft act on space activities. The new act will regulate, among others: rules for conducting space activities, as well as the conditions and procedure for issuing a permit to conduct space activities. Space activities will be able to be carried out only after obtaining a permit granted by the President of the Polish Space Agency.
Publication date: April 03, 2024
The sale of a new drug or medical device and clinical trials is a process between two opposing interest groups. On the one hand, it is about patient protection and the safety of the pharmaceutical market. On the other hand, it is about creating a legal environment that will accelerate the creation of new drugs.
Both goals are important. It is important to create the right legal balance. The balance between patient protection and facilitation of modern medicines and medical devices makes Europe attractive for locating new innovations in technology and creating new medicines and medical devices.
Placing legal priorities in creating law is a political compromise between the speed of producing a new drug and blocking innovation justified by patient safety.
The attractiveness of Europe for the pharmaceutical business compared to other global markets depends on the proper placement of priorities.
